Gene Therapy Focus Target Frontera Therapeutics as a clinical-stage biotech with a strong gene therapy pipeline and recent ARVO/ASGCT presentations, highlighting opportunities for collaboration on gene delivery platforms, regulatory support, and potential partnerships in ophthalmology and broader genetic diseases.

Global Access Position the company’s stated aim of making therapies accessible regardless of geography or livelihood as a sales angle to offer scalable manufacturing, supply chain optimization, and regional distribution solutions to expand patient reach in underserved markets.

Financial Leverage Leverage their $160M Series B funding and mid-market revenue profile to propose value-added services such as clinical-grade manufacturing optimization, quality control automation, and strategic financing partnerships to accelerate development timelines.

Digital Stack Identify opportunities to streamline operations using their existing tech stack (AWS, Microsoft Dynamics, Smartsheet, QuickBooks) by offering integrated data workflows, ERP optimization, and cloud-based collaboration tools that reduce cycle times and improve compliance.

Thought Leadership Capitalize on their active conference presence and research achievements by offering sponsorship, collaborative R&D programs, and analytics services that amplify their science communications, patient impact messaging, and stakeholder engagement.